Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospital Universitari Vall d'Hebron Research Institute
A multicenter, randomized rater-blinded controlled trial was carried out in a sample of 119 adolescents (15-21 years) and was conducted between April 2012- May 2014. Patients were randomly assigned to 12 group manualized cognitive-behavioural group therapy sessions (n=45) or a waiting list control group (N=44). Primary outcomes were assessed by a blind evaluator (ADHD Rating Scale, Clinical Global Impression Scale for Severity, Global Assessment Functioning) before and after treatment as well as by self-report and parent informant ratings.
Age
15–21
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DSM-IV ADHD diagnosis
age between 15 and 21 years
stabilized doses of medication for ADHD for at least 2 months prior to the study
agreement not to seek out any other psychiatric or psychological treatment during the study.